Probiotic effects on cognitive performance, hippocampal oxidative stress, and structural damage induced by icv STZ in Alzheimer-like rat model
- 14 August 2025
- journal article
- research article
- Published by Springer Nature in Brain Structure and Function
- Vol. 230 (7) , 1-19
Abstract
Alzheimer's disease (AD) is a deteriorating neurodegenerative disorder defined by cognitive decline and neuronal damage, with oxidative stress and neuroinflammation as central pathological features. Emerging evidence suggests the gut-brain axis is a key modulator in neurodegeneration, highlighting probiotics' potential in mitigating AD progression. This study investigates the effects of Lactobacillus acidophilus ATCC4356, Lactobacillus reuteri DSM 17938, and their combination on cognitive performance, oxidative stress, and hippocampal structure in a streptozotocin (STZ)-induced AD-like rat model. Thirty-Five male Sprague–Dawley rats were randomly assigned to five groups: Sham, AD-like model (STZ), STZ + Ac, STZ + Re, and STZ + Comb. The AD-like model was induced via intracerebroventricular (icv) injection of STZ. Probiotics were administered by gavage for 35 days. Behavioral assessments, including the open field test and Morris water maze, were conducted to evaluate cognitive and anxiety-like behaviors. Hippocampal oxidative stress markers, including malondialdehyde (MDA), glutathione, superoxide dismutase, and catalase , were analyzed biochemically. Additionally, stereological techniques were used to assess hippocampal volume and cellular densities. Behavioral results demonstrated significant improvement in anxiety-like behavior and spatial memory in probiotic-treated groups compared to the STZ group. Biochemical analysis revealed reduced MDA levels and enhanced antioxidant markers following probiotic intervention. Histological and stereological analyses indicated increased neuronal density and reduced glial cell activation in hippocampal subregions (CA1, CA3, DG), though hippocampal volume loss remained unaltered. These findings underscore the neuroprotective potential of probiotics in alleviating AD-related neurodegeneration, possibly through antioxidative and anti-inflammatory mechanisms. Further pre-clinical studies are warranted to optimize probiotic regimens for AD prevention and treatment.Keywords
This publication has 94 references indexed in Scilit:
- The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the ratJournal of Psychiatric Research, 2008
- Lipid Peroxidation and Antioxidant Enzyme Activities in Vascular and Alzheimer DementiasNeurochemical Research, 2007
- Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling methodNature Protocols, 2006
- Morris water maze: procedures for assessing spatial and related forms of learning and memoryNature Protocols, 2006
- Metals, Toxicity and Oxidative StressCurrent Medicinal Chemistry, 2005
- The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a reviewEuropean Journal of Pharmacology, 2003
- Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairmentLife Sciences, 2001
- Short Nissl Staining for Incubated Cryostat Sections of the BrainBiotechnic & Histochemistry, 1991
- The efficiency of systematic sampling in stereology and its prediction*Journal of Microscopy, 1987
- Assay for lipid peroxides in animal tissues by thiobarbituric acid reactionAnalytical Biochemistry, 1979